C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death

被引:113
作者
den Hertog, H. M. [1 ]
van Rossum, J. A. [1 ]
van der Worp, H. B. [2 ]
van Gemert, H. M. A. [3 ]
de Jonge, R. [1 ]
Koudstaal, P. J. [1 ]
Dippel, D. W. J. [1 ]
机构
[1] Univ Med Ctr Rotterdam, Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands
[2] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands
[3] Meander Med Ctr, Amersfoort, Netherlands
关键词
C-reactive protein; Ischemic stroke; Clinical outcome; Prognostic factor; Inflammation; INFECTION; TRIAL; THROMBOLYSIS; PRAVASTATIN; INFARCTION; INCREASES; MEDIATORS; THERAPY; SUBTYPE; CRP;
D O I
10.1007/s00415-009-5228-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Acute ischemic stroke may trigger an inflammatory response that leads to increased levels of C-reactive protein (CRP). High levels of CRP may be associated with poor outcome because they reflect either an inflammatory reaction or tissue damage. We evaluated the prognostic value of CRP within 12 h of onset of ischemic stroke. Levels of CRP were routinely obtained within 12 h of symptom onset in 561 patients with ischemic stroke. CRP values were dichotomized as < 7 or a parts per thousand yen7 mg/L. The full range of CRP values was used to detect a possible level-risk relationship. We studied the relation between CRP values and poor outcome (modified Rankin Scale score > 2) or death at 3 months. A multiple logistic regression model was applied to adjust for age, sex, NIHSS score, current cigarette smoking, diabetes mellitus, hypertension, statin use, and stroke subtype. After adjustment for potential confounders, patients with CRP levels a parts per thousand yen7 mg/L had a significantly increased risk of poor outcome (adjusted OR 1.6, 95% CI 1.1-2.4) or death (adjusted OR 1.7, 95% CI 1.0-2.9) at 3 months. In addition, the risk of poor outcome or death at 3 months increased with higher levels of CRP. CRP within 12 h of ischemic stroke is an independent prognostic factor of poor outcome at 3 months.
引用
收藏
页码:2003 / 2008
页数:6
相关论文
共 30 条
  • [1] CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL
    ADAMS, HP
    BENDIXEN, BH
    KAPPELLE, LJ
    BILLER, J
    LOVE, BB
    GORDON, DL
    MARSH, EE
    KASE, CS
    WOLF, PA
    BABIKIAN, VL
    LICATAGEHR, EE
    ALLEN, N
    BRASS, LM
    FAYAD, PB
    PAVALKIS, FJ
    WEINBERGER, JM
    TUHRIM, S
    RUDOLPH, SH
    HOROWITZ, DR
    BITTON, A
    MOHR, JP
    SACCO, RL
    CLAVIJO, M
    ROSENBAUM, DM
    SPARR, SA
    KATZ, P
    KLONOWSKI, E
    CULEBRAS, A
    CAREY, G
    MARTIR, NI
    FICARRA, C
    HOGAN, EL
    CARTER, T
    GURECKI, P
    MUNTZ, BK
    RAMIREZLASSEPAS, M
    TULLOCH, JW
    QUINONES, MR
    MENDEZ, M
    ZHANG, SM
    ALA, T
    JOHNSTON, KC
    ANDERSON, DC
    TARREL, RM
    NANCE, MA
    BUDLIE, SR
    DIERICH, M
    HELGASON, CM
    HIER, DB
    SHAPIRO, RA
    [J]. STROKE, 1993, 24 (01) : 35 - 41
  • [2] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
    Albert, MA
    Danielson, E
    Rifai, N
    Ridker, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70
  • [3] Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial
    Aslanyan, S
    Weir, CJ
    Diener, HC
    Kaste, M
    Lees, KR
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (01) : 49 - 53
  • [4] Inflammatory mediators and stroke: New opportunities for novel therapeutics
    Barone, FC
    Feuerstein, GZ
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (08) : 819 - 834
  • [5] MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE
    BROTT, T
    ADAMS, HP
    OLINGER, CP
    MARLER, JR
    BARSAN, WG
    BILLER, J
    SPILKER, J
    HOLLERAN, R
    EBERLE, R
    HERTZBERG, V
    RORICK, M
    MOOMAW, CJ
    WALKER, M
    [J]. STROKE, 1989, 20 (07) : 864 - 870
  • [6] C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke
    Christensen, H
    Boysen, G
    [J]. CEREBROVASCULAR DISEASES, 2004, 18 (03) : 214 - 219
  • [7] PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480] (vol 8, pg 29, 2008)
    den Hertog, Heleen M.
    van der Worp, H. Bart
    van Gemert, H. Maarten A.
    Algra, Ale
    Kappelle, L. Jaap
    van Gijn, Jan
    Koudstaal, Peter J.
    Dippel, Diederik W. J.
    [J]. BMC CARDIOVASCULAR DISORDERS, 2008, 8 (1)
  • [8] Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke - A statement for health care professionals from the CRP pooling project members
    Di Napoli, M
    Schwaninger, M
    Cappelli, R
    Ceccarelli, E
    Di Gianfilippo, G
    Donati, C
    Emsley, HCA
    Forconi, S
    Hopkins, SJ
    Masotti, L
    Muir, KW
    Paciucci, A
    Papa, F
    Roncacci, S
    Sander, D
    Sander, K
    Smith, CJ
    Stefanini, A
    Weber, D
    [J]. STROKE, 2005, 36 (06) : 1316 - 1329
  • [9] Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke
    Di Napoli, M
    Papa, F
    Bocola, V
    [J]. STROKE, 2001, 32 (01) : 133 - 138
  • [10] C-reactive protein in ischemic stroke - An independent prognostic factor
    Di Napoli, M
    Papa, F
    Bocola, V
    [J]. STROKE, 2001, 32 (04) : 917 - 924